Iron deficiency develops in a meaningful percentage of patients on GLP-1 receptor agonists like semaglutide, often appearing 3-6 months into treatment
Lintervention, ralise sous anesthsie locale ou gnrale selon les cas, laisse des cicatrices quasi invisibles
Animal and clinical studies have shown that GLP-1RAs ameliorate liver inflammation and lower the risk of NAFLD and NASH developing into liver cancer
These cytokines do not just cause inflammation
3 The takeaway: Behavior change matters to people on GLP-1s, and the Noom app continues to be associated with stronger real-world GLP-1 outcomes Taken together, these findings tell a clear story: people who pair GLP-1 medication with consistent engagement in the Noom app see more success at weight loss, and, independently, they stay with the program longer
(2011) 128:94855.e941-943